Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs

被引：2
|
作者：
Holden, Sarah E. [1 ]
Bannister, Christian A. [1 ]
Currie, Craig J. [1 ]
机构：
[1] Cardiff Univ, Cardiff Medictr, Pharma Res Ctr, Sch Med, Cardiff CF14 4UJ, S Glam, Wales
来源：
DIABETOLOGIA | 2014年 / 57卷 / 09期
基金：
英国医学研究理事会;
关键词：
Cancer; Diabetes; Diabetes duration; Insulin; Mortality; Treatment;
D O I：
10.1007/s00125-014-3281-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2001 / 2002
页数：2
相关论文
共 50 条
  • [41] The effect of glucose variability on QTc duration and dispersion in patients with Type 2 Diabetes Mellitus
    Sertbas, Yasar
    Ozdemir, Ali
    Sertbas, Meltem
    Dayan, Akin
    Sancak, Seda
    Uyan, Cihangir
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (01) : 22 - 26
  • [42] Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes
    Dunvald, Ann-Cathrine Dalgard
    Nielsen, Flemming
    Olsen, Dorte Aalund
    Ernst, Martin Thomsen
    Donnelly, Louise
    Soto-Pedre, Enrique
    Kristiansen, Maja Refshauge
    Nielsen, Jens Steen
    Persson, Frederik
    Hojlund, Kurt
    Madsen, Jonna Skov
    Sondergaard, Jens
    Pearson, Ewan
    Pottegard, Anton
    Stage, Tore Bjerregaard
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (08) : 2529 - 2541
  • [43] The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes
    Lega, Iliana C.
    Shah, Prakesh S.
    Margel, David
    Beyene, Joseph
    Rochon, Paula A.
    Lipscombe, Lorraine L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 1974 - 1984
  • [44] Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
    Doupis, John
    Alexandrides, Theodoros
    Elisaf, Moses
    Melidonis, Andreas
    Bousboulas, Stavros
    Thanopoulou, Anastasia
    Pagkalos, Emmanouil M.
    Avramidis, Iakovos
    Pappas, Angelos
    Arvaniti, Eleni
    Karamousouli, Eugenia
    Voss, Bernd
    Tentolouris, Nikolaos
    DIABETES THERAPY, 2019, 10 (04) : 1407 - 1422
  • [45] Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study
    Fadini, Gian Paolo
    Frison, Vera
    Simioni, Natalino
    Lapolla, Annunziata
    Gatti, Adriano
    Bossi, Antonio Carlo
    Del Buono, Andrea
    Fornengo, Paolo
    Gottardo, Lucia
    Laudato, Mario
    Perseghin, Gianluca
    Sonora, Enzo
    Avogaro, Angelo
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (14):
  • [46] Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes
    Zhang, Peng
    Jiang, Qing
    Ding, Bo
    Yan, Reng-Na
    Hu, Yun
    Ma, Jian-Hua
    WORLD JOURNAL OF DIABETES, 2024, 15 (07)
  • [47] Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes
    Christiaens, Antoine
    Boland, Benoit
    Germanidis, Marie
    Dalleur, Olivia
    Henrard, Severine
    BMC GERIATRICS, 2020, 20 (01) : 367
  • [48] Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer
    Kusne, Yael N.
    Kosiorek, Heidi E.
    Buras, Matthew R.
    Coppola, Kyle E.
    Verona, Patricia M.
    Cook, Curtiss B.
    Karlin, Nina J.
    FUTURE SCIENCE OA, 2021, 7 (03):
  • [49] Initial glucose-lowering therapy and risks of overall and cardiovascular mortality, myocardial infarction and stroke in patients with type 2 diabetes
    Misnikova, I. V.
    Dreval, A. V.
    Kovaleva, Yu. A.
    DIABETES MELLITUS, 2009, 12 (04): : 72 - 79
  • [50] Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
    Mellbin, L. G.
    Malmberg, K.
    Norhammar, A.
    Wedel, H.
    Ryden, L.
    DIABETOLOGIA, 2011, 54 (06) : 1308 - 1317
12345